
Cancer Research p. 3001 - 3012 (2017)
Update date:2022-07-29
Topics:
Li, Rui
Ding, Chunyong
Zhang, Jun
Xie, Maohua
Park, Dongkyoo
Ding, Ye
Chen, Guo
Zhang, Guojing
Gilbert-Ross, Melissa
Zhou, Wei
Marcus, Adam I.
Sun, Shi-Yong
Chen, Zhuo G.
Sica, Gabriel L.
Ramalingam, Suresh S.
Magis, Andrew T.
Fu, Haian
Khuri, Fadlo R.
Curran, Walter J.
Owonikoko, Taofeek K.
Shin, Dong M.
Zhou, Jia
Deng, Xingming
A rationale exists for pharmacologic manipulation of the serine (S)184 phosphorylation site of the proapoptotic Bcl2 family member Bax as an anticancer strategy. Here, we report the refinement of the Bax agonist SMBA1 to generate CYD-2-11, which has characteristics of a suitable clinical lead compound. CYD-2-11 targeted the structural pocket proximal to S184 in the C-terminal region of Bax, directly activating its proapoptotic activity by inducing a conformational change enabling formation of Bax homooligomers in mitochondrial membranes. In murine models of small-cell and non-small cell lung cancers, including patient-derived xenograft and the genetically engineered mutant KRAS-driven lung cancer models, CYD-2-11 suppressed malignant growth without evident significant toxicity to normal tissues. In lung cancer patients treated with mTOR inhibitor RAD001, we observed enhanced S184 Bax phosphorylation in lung cancer cells and tissues that inactivates the propaoptotic function of Bax, contributing to rapalog resistance. Combined treatment of CYD-2-11 and RAD001 in murine lung cancer models displayed strong synergistic activity and overcame rapalog resistance in vitro and in vivo. Taken together, our findings provide preclinical evidence for a pharmacologic combination of Bax activation and mTOR inhibition as a rational strategy to improve lung cancer treatment.
Tianjin Ingenochem Technology Co.,Ltd
Contact:+86-22-23677060
Address:Hitech Green Industry Park K2-9-602, Nankai district
Changzhou Yongxu Chemical Co.,Ltd
Contact:86-0519-85286591
Address:Room 1812,Wanda Plaza B,Xinbei District,Changzhou,Jiangsu,China
Zhuhai Rundu Pharmaceutical co.,Ltd
Contact:+86-756-7630755
Address:No.6,North Airport Road,Sanzao Town,Jinwan District
Shanghai Hohance Chemical Co., ltd
Contact:13914753421
Address:Fl.5;Bld. 70, Lane 1500; Xinfei Road
Xiamen Goodhealth Pharmchem Co., Ltd.
Contact:0086-592-2097683
Address:404R No.2 54# Minzu Rd., Xiamen, China
Doi:10.1021/ol400280b
(2013)Doi:10.1002/chir.22101
(2012)Doi:10.1021/acs.orglett.0c03521
(2020)Doi:10.1021/jo00043a025
(1992)Doi:10.1016/j.tetlet.2013.01.041
(2013)Doi:10.1021/ol702892e
(2008)